Skip to content
Screener

Celcuity CELC Investing Cash Flow

Investing Cash Flow at other companies

Eli Lilly logo
Eli LillyLLY
-$15.4B-739%
Gilead Sciences logo
Gilead SciencesGILD
-$10.35B-389%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$42.74M-2,579%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-$353.03M-570%
Immunome logo
ImmunomeIMNM
-$12.02M-336%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
-$17.98M-180%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.55B+150%
Enterprise value$4.54B+142%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Celcuity’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 5:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-023180
Line item2026 / Three Months Ended March 31,2025 / Three Months Ended March 31,
Purchases of investments(15,196)(42,486)
Purchases of property and equipment(249)(60)
Purchases of capitalized software(36)
Net cash provided by investing activities34,51924,262
Cash flows from financing activities:
Proceeds from exercise of common stock options206
Proceeds from exercise of common stock warrants315,600
Payments for secondary registration statement costs(203)(46)

Item 1. Financial Statements (unaudited) ITEM

FAQ

What is Celcuity's investing cash flow?
Celcuity (CELC) reported investing cash flow of $34.52M in Q1 2026.
How has Celcuity's investing cash flow changed year-over-year?
Celcuity's investing cash flow increased by 42.3% year-over-year, from $24.26M to $34.52M.
What is the long-term trend for Celcuity's investing cash flow?
Over 2 years (2021 to 2023), Celcuity's investing cash flow has grown at a 684.4% compound annual growth rate (CAGR), from -$81.4K to -$5.01M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Celcuity's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude